Tenax Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2011
Total Assets: $2.9M
Liabilities Breakdown FY2011
Total Liabilities: $6.6M
Asset Breakdown
Total Assets: $2.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $951.9K | 32.6% |
| Accounts Receivable | $138.9K | 4.8% |
| Inventory | $257.4K | 8.8% |
| Property, Plant & Equipment | $442.6K | 15.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $700.0K | 24.0% |
| Other Assets | $431.6K | 14.8% |
Liabilities Breakdown
Total Liabilities: $6.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $889.4K | 13.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $5.8M | 86.6% |